{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Roivant Sciences Ltd."},"Symbol":{"label":"Symbol","value":"ROIV"},"Address":{"label":"Address","value":"11-12 ST. JAMES'S SQUARE,SUITE 1, 3RD FLOOR, LONDON, SW1Y 4LB, United Kingdom"},"Phone":{"label":"Phone","value":"+44 2074003347"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"Roivant Sciences Ltd is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients."},"CompanyUrl":{"label":"Company Url","value":"https://www.roivant.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Drew Kramer","title":"Chief Information Officer"},{"name":"Eric Venker","title":"Co-President & Chief Operating Officer"},{"name":"Matthew Gline","title":"Chief Executive Officer & Director"},{"name":"Mayukh Sukhatme","title":"Co-President, Director & Chief Investment Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}